Peptitrol delivery system (Shire)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePeptitrol delivery system (Shire)
Drug Alias NameDHE-IR (Shire)GnRH agonists (Shire)aciclovir (Shire)dihydroergotamine (Shire)calcitonin (Shire) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusEndometriosisMigraine Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSupernus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & CoSupernus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusEndometriosisMigraine Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksN/A